Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Biorxiv : the Preprint Server for Biology|September 30, 2020
Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein's Receptor Binding Domain and Recombinant Human ACE2Omonike A Olaleye, Manvir Kaur, Collins C OnyenakaInformatics in Medicine Unlocked|September 12, 2022
A computational evaluation of structural stability of omicron and delta mutations of SARS-CoV-2 spike proteins and human ACE-2 interactionsKehinde A Idowu, Collins Onyenaka, Omonike A OlaleyeTuberculosis (Edinburgh, Scotland)|December 17, 2009
Targeting the role of N-terminal methionine processing enzymes in Mycobacterium tuberculosisOmonike A Olaleye, William R Bishai, Jun O LiuBiorxiv : the Preprint Server for Biology|August 21, 2020
Discovery of Clioquinol and Analogues as Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection, ACE2 and ACE2 - Spike Protein Interaction <i>In Vitro</i>Omonike A Olaleye, Manvir Kaur, Collins Onyenaka, et al.Heliyon|March 18, 2021
Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction <i>in vitro</i>Omonike A Olaleye, Manvir Kaur, Collins Onyenaka, et al.Journal of Molecular Graphics & Modelling|April 29, 2022
Inhibitory mechanism of Ambroxol and Bromhexine Hydrochlorides as potent blockers of molecular interaction between SARS-CoV-2 spike protein and human angiotensin-converting Enzyme-2Idowu A Kehinde, Anu Egbejimi, Manvir Kaur, et al.Journal of Biomolecular Structure & Dynamics|February 28, 2022
Inhibitory mechanism of clioquinol and its derivatives at the exopeptidase site of human angiotensin-converting enzyme-2 and receptor binding domain of SARS-CoV-2 viral spikeIdowu A Kehinde, Anu Egbeyemi, Manvir Kaur, et al.International Journal of Molecular Sciences|December 23, 2023
Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine AminopeptidaseCollins Onyenaka, Kehinde A Idowu, Ngan P Ha, et al.Drug Design, Development and Therapy|April 14, 2020
Pre-Clinical Pharmacokinetics, Tissue Distribution and Physicochemical Studies of CLBQ14, a Novel Methionine Aminopeptidase Inhibitor for the Treatment of Infectious DiseasesOscar Ekpenyong, Xiuqing Gao, Jing Ma, et al.International Journal of MCH and AIDS|August 9, 2020
Role of Social Determinants of Health in Widening Maternal and Child Health Disparities in the Era of Covid-19 PandemicDeepa Dongarwar, Veronica B Ajewole, Emmanuella Oduguwa, et al.Pageof 3